Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 712-722
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.712
Figure 4
Figure 4 Correlation between serum lipopolysaccharide-binding protein and EndoCab IgG in 126 biopsy-proven nonalcoholic fatty liver disease patients. A correlation efficient (r) and P value were calculated using Spearman’s test. LBP: Lipopolysaccharide-binding protein.